Nanobodies
have gained widespread application in immunoassays.
However, their small size presents a significant challenge in achieving
effective immobilization and optimal sensitivity. Here, we present
a novel “one-for-two”-oriented immobilization platform
based on an organism-bispecific nanobody (O-BsNb) scaffold, enabling
highly sensitive detection of two bacterial pathogens. Through genetic
engineering, a bispecific nanobody (BsNb) was engineered, targeting Salmonella spp. and Vibrio parahaemolyticus. The O-BsNb scaffold allowed one nanobody to bind specifically to
inactivated bacteria, forming an organism-oriented immobilization
platform, while the other served as the capture antibody. Consequently,
the O-BsNb bioscaffold-based ELISA (O-ELISA) for individual detection
of S. enteritidis and V. parahaemolyticus was established. When compared
to the sandwich ELISA utilizing passive immobilization of monovalent
nanobodies, the O-ELISA exhibited a remarkable 13.4- and 13.7-fold
improvement in LOD for S. enteritidis and V. parahaemolyticus, respectively,
highlighting the enhanced immobilization efficacy of the O-ELISA.
Furthermore, the feasibility and reproducibility of the assay in practical
samples were meticulously evaluated, revealing exemplary performance
in terms of recovery precision and assay stability. These findings
demonstrate the significant potential of the O-ELISA platform for
the sensitive detection of macromolecules, opening new avenues for
efficient pathogen identification in foodborne safety and clinical
diagnostics.